XM tillhandahåller inte tjänster till personer bosatta i USA.

Megacaps boost futures as Wall Street stays upbeat ahead of data, earnings



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>US STOCKS-Megacaps boost futures as Wall Street stays upbeat ahead of data, earnings</title></head><body>

For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window.

Powell due to speak at 10 a.m. ET

TSMC up on strong Q2 revenue growth

Illumina rises after acquiring Fluent BioSciences

Goodyear Tire up after report Yokohama's plans to buy unit

Futures: Dow flat, S&P 500 up 0.14%, Nasdaq up 0.27%

Updated at 7:26 a.m. ET

By Lisa Pauline Mattackal and Ankika Biswas

July 10 (Reuters) -S&P 500 and Nasdaq futures rose ina record-breaking Wall Street rally on Wednesday, on continued strength in heavily weighted stocks, withFederal Reserve Chair Jerome Powell's remarks and crucial inflation prints set to offer more direction this week.

AI-chip favorite Nvidia NVDA.O climbed 1.1% in premarket trading, after hitting a near three-week high in the previous session.

Other chip stocks including Arm Holdings ARM.O and Micron Technology gained around 1% each, with U.S.-listed shares of Taiwan Semiconductor Manufacturing Co TSM.N, the world's largest contract chipmaker, climbing 2% after its second-quarter revenue handily beat estimates.

All the so-called "Magnificent Seven" stocks were trading higher, with U.S. Treasury yields falling. Meta Platforms META.O, Apple AAPL.O, Alphabet GOOGL.O and Microsoft MSFT.O were up around 0.4% each.

Tesla TSLA.O, too, edgedup 0.5% after HSBC hiked its price target on the EV maker's stock, whichclocked its longest winning streak of10 sessions this yearon Tuesday.

The group of seven stocks has been the main force behind Wall Street's banner rally this year, while the broader market has lagged, leading some market watchers to question the sustainability of equity gains and call for greaterdiversification.

The benchmark S&P 500 .SPX closed at an all-time high for the fifth straight session on Tuesday, whilethe tech-heavy Nasdaq .IXIC notched its sixth record closing high, after hopes for an interest-rate cut in September received a boost fromJerome Powell, who said theU.S. was "no longer an overheated economy".

However, as expected, Powell refrained from committing to a timeline for rate cuts in his testimony to Congress. He is slated to appear before the House Financial Services Committee at 10 a.m. ET for further questioning from lawmakers.

"We believe Powell is happy with keeping markets relatively quiet at this stage as some data starts to go in the right direction, we did read a still modestly dovish bias in Powell’s testimony, as he kept adding emphasis on the risks of unduly weakening activity and employment," analysts at ING said in a note.

Bets on a 25-basis-point rate cut by September have hovered around 70% for the past week, up from 45% a month ago, according to CME's FedWatch. Comments from Fed officials Austan Goolsbee, Michelle Bowman and Lisa Cook are also expected through the day.

Attention will now shift to U.S. inflation data this week, with the ConsumerPrice Index due on Thursday and the Producer Price Index report on Friday.

The second-quarter earnings season, which kicks off this week with major banks due to report onFriday, will be a key test for whether high-flying megacaps can justify expensive valuations and continue their strong runs.

At 7:26 a.m. ET, Dow e-minis 1YMcv1 were down 4 points, or 0.01%, S&P 500 e-minis EScv1 were up 8 points, or 0.14%, and Nasdaq 100 e-minis NQcv1 were up 55.25 points, or 0.27%.

Gene-sequencing equipment maker Illumina ILMN.O jumped 3.7% on plans to acquire privately held Fluent BioSciences.

Goodyear Tire & Rubber Company GT.O gained 2% aftera report that Japan's Yokohama Rubber was in talks to buy its off-road tire business for at least $1 billion.



Reporting by Lisa Mattackal and Ankika Biswas in Bengaluru; Editing by Pooja Desai

</body></html>

Ansvarsfriskrivning: XM Group-enheter tillhandahåller sin tjänst enbart för exekvering och tillgången till vår onlinehandelsplattform, som innebär att en person kan se och/eller använda tillgängligt innehåll på eller via webbplatsen, påverkar eller utökar inte detta, vilket inte heller varit avsikten. Denna tillgång och användning omfattas alltid av i) villkor, ii) riskvarningar och iii) fullständig ansvarsfriskrivning. Detta innehåll tillhandahålls därför uteslutande som allmän information. Var framför allt medveten om att innehållet på vår onlinehandelsplattform varken utgör en uppmaning eller ett erbjudande om att ingå några transaktioner på de finansiella marknaderna. Handel på alla finansiella marknader involverar en betydande risk för ditt kapital.

Allt material som publiceras på denna sida är enbart avsett för utbildnings- eller informationssyften och innehåller inte – och ska inte heller anses innehålla – rådgivning och rekommendationer om finansiella frågor, investeringsskatt eller handel, dokumentation av våra handelskurser eller ett erbjudande om, eller en uppmaning till, en transaktion i finansiella instrument eller oönskade finansiella erbjudanden som är riktade till dig.

Tredjepartsinnehåll, liksom innehåll framtaget av XM såsom synpunkter, nyheter, forskningsrön, analyser, kurser, andra uppgifter eller länkar till tredjepartssajter som återfinns på denna webbplats, tillhandahålls i befintligt skick, som allmän marknadskommentar, och utgör ingen investeringsrådgivning. I den mån som något innehåll tolkas som investeringsforskning måste det noteras och accepteras att innehållet varken har varit avsett som oberoende investeringsforskning eller har utarbetats i enlighet med de rättsliga kraven för att främja ett sådant syfte, och därför är att betrakta som marknadskommunikation enligt tillämpliga lagar och föreskrifter. Se till så att du har läst och förstått vårt meddelande om icke-oberoende investeringsforskning och riskvarning om ovannämnda information, som finns här.

Riskvarning: Ditt kapital riskeras. Hävstångsprodukter passar kanske inte alla. Se vår riskinformation.